Page last updated: 2024-12-08

blp 1654

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

BLP 1654: RN given refers to (2S-(2alpha,5alpha,6beta(S*))-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID193642
MeSH IDM0054621

Synonyms (11)

Synonym
28889-87-4
blp 1654
(2s-(2alpha,5alpha,6beta(s*)))-6-((((((aminoiminomethyl)amino)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
blp-1654
0bl51c9681 ,
d-6-(2-(3-amidinoureido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-(d-alpha-(3-guanylureido)phenylacetamido)penicillanic acid
unii-0bl51c9681
bl p1654
DTXSID00951523
6-[(2-{[carbamimidamido(hydroxy)methylidene]amino}-1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The half-life of BL-P1654 (2."( Human pharmacokinetics of BL-P1654 compared with ampicillin.
Clarke, JT; Kirby, WM; Libke, RD; Luthy, RP; Ralph, ED, 1974
)
0.25
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]